{"contentid": 488546, "importid": NaN, "name": "Oncimmune and Genostics Company part ways in China", "introduction": "Nottingham, UK-based immunodiagnostics specialist Oncimmune has taken back certain IP and distribution rights for its EarlyCDT technology.", "content": "<p>Nottingham, UK-based immunodiagnostics specialist Oncimmune (AIM: ONC.L) has taken back certain intellectual property (IP) and distribution rights for its EarlyCDT technology.</p>\n<p>The firm out-licensed Chinese rights to the platform to Genostics Company in January 2018, and the companies have collaborated since then with the goal of developing a lung panel with superior performance.</p>\n<p>The use of EarlyCDT - a simple blood test that detects the elevated presence of autoantibodies generated by cancer - is particularly valuable in the region, given the prevalence of EGFR-positive non-small cell lung cancer (NSCLC).</p>\n<p>The Asia-specific lung panel has been used in a multi-center study which is now due to complete in the first part of 2021.</p>\n<p>Data from this study are intended to support approval by the China National Medical Products Administration (NMPA) for the use of the Asia-specific lung cancer test in China.</p>\n<h2>US capital markets</h2>\n<p>Under the new agreement, all materials, IP and data will be transferred back to Oncimmune, which will be paid in full for royalties due in January 2021.</p>\n<p>The firm will pay a fixed amount for the return of the IP and distribution rights, with the majority of the value of the consideration being conditional on fixed future events.</p>\n<p>Oncimmune is focused on growing its ImmunoINSIGHTS business, and said it intends to explore options available to access the US capital markets, &ldquo;in the near term.&rdquo;</p>\n<p>Chief executive Adam Hill said: &ldquo;We are grateful for the collaboration with Genostics and its parent company, Gene Group Holdings Ltd, over the past three years and are pleased with the progress that has been made with our Asia-specific lung panel.&rdquo;</p>\n<p>&ldquo;However, as both companies consider their future on different equity capital markets, the continuing success of the EarlyCDT product portfolio, both in and outside of PRC and HK, requires Oncimmune to own the IP and distribution rights,&rdquo; he added.</p>", "date": "2021-05-05 12:38:00", "meta_title": NaN, "meta_keywords": "Oncimmune, rights, EarlyCDT, lung, distribution, China, company, Genostics, part, ways, cancer, specialist, technology, Nottingham, UK-based, panel, capita", "meta_description": "Nottingham, UK-based immunodiagnostics specialist Oncimmune has taken back certain IP and distribution rights for its EarlyCDT technology.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-05 12:38:34", "updated": "2021-05-05 16:20:08", "access": NaN, "url": "https://www.thepharmaletter.com/article/oncimmune-and-genostics-company-part-ways-in-china", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "lab_biotech_test_big.jpg", "image2id": "lab_biotech_test_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Genomics, Oncology", "topic_tag": "Asia Pacific, Deals, Focus On, Licensing, Management, Research", "geography_tag": "China, UK", "company_tag": "Genostics Company, Oncimmune", "drug_tag": "EarlyCDT", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-05 12:38:00"}